November 2019 PMID 31630538

Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring: A Randomized Clinical Trial.

Jason G Andrade, Jean Champagne, Marc Dubuc, Marc W Deyell, Atul Verma, Laurent Macle, Peter Leong-Sit, Paul Novak, Mariano Badra-Verdu, John Sapp, Iqwal Mangat, Clarence Khoo, Christian Steinberg, Matthew T Bennett, Anthony S L Tang

Full text PDF Download social card

Mentions

137

Peak: 47 in Aug 2023

across 5 sources since Nov 2019

Extended reach

618,343

potential audience

Total likes

1,081

Video views

70,365

Mentions per month

Nov 2019 – Feb 2025

Where it's discussed

X / Twitter122 posts
News6 articles
Facebook4 posts
Blogs3 articles
YouTube2 videos

AI synopsis

What people are saying

Several discussions highlight specific details from the study, such as one user referencing the 98% reduction in AF burden seen in the CIRCA-DOSE trial. Others mention comparative results between radiofrequency and cryoablation, using phrases like 'interesting question' and 'seems compelling' that convey an analytical tone and enthusiasm for the research findings. The tone is generally supportive and inquisitive, which contributes to the overall high sentiment around the impact and relevance of the publication.

AgreementModerate agreement

The majority of discussions reflect a supportive stance towards the findings of the clinical trial, indicating a general consensus among the participants.

InterestHigh interest

Posts indicate a high level of curiosity and relevance to current medical practices, particularly in the context of atrial fibrillation treatments.

EngagementModerate engagement

While many posts provide summaries and discussions on the trial's methodologies, there are also some that exhibit deeper analysis of related studies.

ImpactHigh impact

Many users believe the study has significant implications for atrial fibrillation treatment, suggesting that its findings could influence future clinical practices.

Abstract in brief

The study assessed the effectiveness of contact force-guided radiofrequency ablation (CFRF) and two types of cryoballoon ablation (Cryo4 and Cryo2) in treating patients with drug-refractory paroxysmal atrial fibrillation (AF).
Results showed one-year freedom from atrial tachyarrhythmia rates were 53.9% (CFRF), 52.2% (Cryo4), and 51.7% (Cryo2), while freedom from symptomatic arrhythmias was higher in CFRF at 79.1% compared to the cryoballoon groups.
Though CFRF had a longer procedure time, it resulted in less fluoroscopy exposure, and adverse events rates were similar across all groups, indicating comparable safety profiles.

Read the full abstract

All mentions

Comparative Effectiveness of Atrial Fibrillation Ablation Methods

This video examines who is an appropriate candidate for atrial fibrillation and the most successful treatment methods. Dr. William Hucker discusses contact force-guided radiofrequency and cryoballoon ablation…

Harvard Medical School Continuing Education · Apr 5, 2023 69,863 views

AF Ablation Techniques: Efficacy of CFRF vs Cryoballoon Methods

The effectiveness of contact force-guided radiofrequency ablation and two cryoballoon types in treating drug-refractory atrial fibrillation is discussed. Key findings reveal comparable safety profiles and varied success…

Medscape · Feb 21, 2025 503 views